Choksi Imaging Share Price

Choksi Imaging Investment Rating

• Master Rating:

• Choksi Laboratories has an operating revenue of Rs. 32.94 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of 1% needs improvement, ROE of 1% is fair but needs improvement. The company has a high debt to equity of 154%, which can be a reason to worry. It is currently FORMING a base in its weekly chart and is trading around 15% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 71 which is a FAIR score but needs to improve its earnings, a RS Rating of 78 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 60 indicates it belongs to a fair industry group of Medical-Research Eqp/Svc and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.